Press release
Cholesterol Lowering Biologic Drugs Market is Expecting Worldwide Growth by 2017 – 2025 : Persistence Market Research
The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad cholesterol. The new class of PCSK-9 inhibitors is being approved by the FDA which works by helping the liver flush out the bad cholesterol instead of preventing the body from making low-density lipoproteins. The FDA has till now approved only two drugs Praluent and Repatha, both made from living things. The PCSK-9 is a protein which binds to the receptors, those which are responsible for getting the bad cholesterol out of the body.Cholesterol Lowering Biologic Drugs Market: Drivers and Restraints
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the country’s population has dyslipidemia, a condition where the individual has abnormal levels of triglycerides or cholesterol. The risk factors are obesity, hypertension poor lifestyle habits and diabetes. Moreover, the demand for biologics is driven by the dramatic shift in production technology and an expansion of targeted diseases.
Cholesterol Lowering Biologic Drugs Market: Overview
There are two types of cholesterol, the good and the bad cholesterol. High-density lipoproteins also known as good cholesterol is responsible for carrying the bad kind to the liver from where it is removed. However, the low density lipoproteins buildup in the arteries which may block them eventually. This decreases or blocks the blood flow from reaching the brain and the heart leading to cases of stroke or heart disease.
The demand for cholesterol lowering biologics drugs is expected to boom with the added advantages it offers over statins. For instance, both Praluent and Repatha are to be taken every two weeks. The FDA, for now, has approved these two biologics drugs for a specific type of hereditary high cholesterol, but the increasing research developments will expand its application for wider high cholesterol audience. In January 2017, the U.S. Federal District court has decided to remove Praluent from the market. The company has been given a 30 days times to appeal the injunction and work towards a solution.
Cholesterol Lowering Biologic Drugs Market: Region-wise Outlook
In terms of geography, cholesterol lowering biologic drugs market has been divided into five regions including North- America, Europe, Asia- Pacific, Latin America and Middle-East & Africa. The population with high-level cholesterol and the presence of FDA-approved biologics is making North America region to dominate the cholesterol lowering biologic drugs market. CDC estimates more than 102 million American’s with high-level cholesterols compared to what’s considered healthy. Of that population of 102 million people, around 35 million have cholesterol levels high enough to put them at risk of heart disease.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/16048
Europe has already seen in few launches in biologics and will see more in coming years. The sales of biologics have overtaken the sales of traditional drugs as these therapies are targeted towards high-value therapies for the chronic condition.Asia-Pacific is the fastest growing region as the market of biosimilars across various players is growing at a high growth rate.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/16048
Cholesterol Lowering Biologic Drugs Market: Key Market Participants
Few of the cholesterol lowering biologics drugs market participants are Amgen Inc., Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals.
To Know About Latest Report Click Here: http://www.persistencemarketresearch.com/market-research/cholesterol-lowering-biologic-drugs-market.asp
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cholesterol Lowering Biologic Drugs Market is Expecting Worldwide Growth by 2017 – 2025 : Persistence Market Research here
News-ID: 594585 • Views: …
More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market
The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and…

Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts.
Forged automotive components are critical to…

Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the…

Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring…
More Releases for Cholesterol
Cholesterol Screening/ Cholesterol Lab Testing Market to Witness Robust Expansio …
Cholesterol Screening/ Cholesterol Lab Testing Market Value reach $ million by 2029, growing at a CAGR of 8% from 2023 to 2029. This blood test calculates the blood's triglyceride and cholesterol levels. High cholesterol level goes undetected, yet it can have serious health repercussions.
Important changes in the business allow key players to attain larger profits. This Cholesterol Screening/ Cholesterol Lab TestingMarket study report is the best way to make changes…
Cholesterol Screening/ Cholesterol Lab Testing Market Size, Share, Trends, Growt …
Market Analysis and Insights: Global Cholesterol Screening/ Cholesterol Lab Testing Market
The research report studies the Cholesterol Screening/ Cholesterol Lab Testing market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its…
Cholesterol Screening/ Cholesterol Lab Testing Services Market 2020 to Growth US …
New York, February 20, 2020: The Cholesterol Screening/ Cholesterol Lab Testing Services Market is expected to exceed more than US$ 17.57 Billion by 2021 at a CAGR of 8% in the given forecast period.
Cholesterol is also one of the part of the substance system that is created by our body to keep our body healthy and well-functioning. Cholesterol plays a very important role in the individuals healthy heart. Cholesterol screening…
Cholesterol Screening/ Cholesterol Lab Testing Services Market 2016 - Industry R …
Global Cholesterol Lab Testing Services Market: Overview
The prevalence of sedentary lifestyles of people is expected to boost the demand for cholesterol lab testing services worldwide. Cholesterol is a waxy, fat-like substance present in the bloodstream, nerve fibers, and bodily organs. A person’s level of cholesterol is determined by factors such as heredity, consumption of food with high amounts of saturated fats (for example, animal products), and metabolic conditions such as…
Cholesterol Screening/ Cholesterol Lab Testing Services Market Development, Key …
Global Cholesterol Lab Testing Services Market: Overview
The prevalence of sedentary lifestyles of people is expected to boost the demand for cholesterol lab testing services worldwide. Cholesterol is a waxy, fat-like substance present in the bloodstream, nerve fibers, and bodily organs. A person’s level of cholesterol is determined by factors such as heredity, consumption of food with high amounts of saturated fats (for example, animal products), and metabolic conditions such as…
Cholesterol Screening/ Cholesterol Lab Testing Services Market Research Report 2 …
Global Cholesterol Lab Testing Services Market: Overview
The prevalence of sedentary lifestyles of people is expected to boost the demand for cholesterol lab testing services worldwide. Cholesterol is a waxy, fat-like substance present in the bloodstream, nerve fibers, and bodily organs. A person’s level of cholesterol is determined by factors such as heredity, consumption of food with high amounts of saturated fats (for example, animal products), and metabolic conditions such as…